Brief: Organogenesis Q4 Revenue USD 99.7 Million
29/02/2024 21:05
Feb 29 (Reuters) - Organogenesis Q4 operating income USD -1.3 million. * Q4 adjusted net income USD 1.9 million * Q4 adjusted EBITDA USD 7.5 million * Q4 net income USD -600 thousand * outlook FY EBITDA USD 5.8-25 million * outlook FY adjusted EBITDA USD 15.8-35 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers